| 1 |
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al. · New England Journal of Medicine
Open access |
16 Oct 2013 |
6,826 |
| 2 |
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Robert Louis Coleman et al. · The Lancet
Open access117 authors |
12 Sep 2017 |
1,729 |
| 3 |
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
Yohann Loriot et al. · New England Journal of Medicine
Open access |
24 Jul 2019 |
1,396 |
| 4 |
The Sperm Chromatin Dispersion Test: A Simple Method for the Determination of Sperm DNA Fragmentation
José Luís Fernández, Lourdes Muriel, Marı́a Teresa Rivero et al. · Journal of Andrology
Open access |
2 Jan 2003 |
657 |
| 5 |
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer
Elena Castro et al. · Journal of Clinical Oncology
|
9 Jan 2019 |
380 |
| 6 |
Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis
Scott Joseph Antonia, Hossein Borghaei, Suresh S. Ramalingam et al. · The Lancet Oncology
Open access |
14 Aug 2019 |
373 |
| 7 |
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Silke Gillessen et al. · Annals of Oncology
Open access |
4 Jun 2015 |
324 |
| 8 |
Turnover time of fluorescent dissolved organic matter in the dark global ocean
Teresa S. Catalá, Isabel Reche, Antonio Fuentes‐Lema et al. · Nature Communications
Open access |
29 Jan 2015 |
322 |
| 9 |
Stromal disrupting effects of nab-paclitaxel in pancreatic cancer
Rafael Álvarez, Mónica Musteanu, Elena García-García et al. · British Journal of Cancer
Open access |
Aug 2013 |
295 |
| 10 |
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
Khalid El Bairi et al. · npj Breast Cancer
Open access554 authors |
Dec 2021 |
288 |
| 11 |
Sperm DNA fragmentation in infertile men with genitourinary infection by Chlamydia trachomatis and Mycoplasma
G. Gallegos, Benito Ramos, Rebeca Santiso et al. · Fertility and Sterility
Open access |
9 Jan 2008 |
250 |
| 12 |
Noninfectious Pneumonitis after Everolimus Therapy for Advanced Renal Cell Carcinoma
Dorothy A. White, Philippe Camus, Masahiro Endo et al. · American Journal of Respiratory and Critical Care Medicine
|
Mar 2010 |
210 |
| 13 |
Effect of sperm DNA fragmentation on pregnancy outcome depends on oocyte quality
Marcos Meseguer, Rebeca Santiso, Nicolás Garrido et al. · Fertility and Sterility
Open access |
21 Jul 2010 |
207 |
| 14 |
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
Aleix Prat et al. · The Lancet Oncology
|
11 Dec 2019 |
206 |
| 15 |
Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen
Miguel Martín, Ana M. Lluch, Miguel Ángel Seguí et al. · Annals of Oncology
Open access |
10 Jun 2006 |
204 |
| 16 |
EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation
Santiago Montes‐Moreno, Lina Odqvist, Julio Alexander Díaz-Pérez et al. · Modern Pathology
Open access |
27 Apr 2012 |
196 |
| 17 |
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative
Philippe Georges Aftimos et al. · Cancer Discovery
Open access |
28 Jun 2021 |
187 |
| 18 |
A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2– advanced breast cancer (BELLE-4)
Miguel Martín, A. Chan, Luc Yves Dirix et al. · Annals of Oncology
Open access |
24 Oct 2016 |
186 |
| 19 |
A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck
Tanguy Y. Seiwert, Jérôme Fayette, Didier Cupissol et al. · Annals of Oncology
Open access |
16 Jun 2014 |
183 |
| 20 |
Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case–control EpiGEICAM study
Adela Castelló et al. · British Journal of Cancer
Open access |
7 Aug 2014 |
183 |
| 21 |
Health-Related Quality of Life 2 Years After Treatment With Radical Prostatectomy, Prostate Brachytherapy, or External Beam Radiotherapy in Patients With Clinically Localized Prostate Cancer
Montse Ferrer, José Francisco Suárez, Ferrán Guedea et al. · International Journal of Radiation Oncology*Biology*Physics
|
6 Mar 2008 |
182 |
| 22 |
SERS Quantification and Characterization of Proteins and Other Biomolecules
Neus Feliu, Moustapha Hassan, Eduardo García‐Rico et al. · Langmuir
|
22 Aug 2017 |
170 |
| 23 |
Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody
James J. Harding, Víctor Moreno, Yung‐Jue Bang et al. · Clinical Cancer Research
Open access |
29 Jan 2021 |
165 |
| 24 |
Characterizing DNA methylation patterns in pancreatic cancer genome
Aik Choon Tan, Antonio Jimeno, Steven Hsesheng Lin et al. · Molecular Oncology
Open access |
22 Apr 2009 |
162 |
| 25 |
FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
Mafalda Oliveira, Cristina Saura, Paolo Giovanni Nuciforo et al. · Annals of Oncology
Open access |
25 May 2019 |
157 |
| 26 |
Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)
Enrique Grande, Jaume Capdevila, Daniel Castellano et al. · Annals of Oncology
Open access |
11 Jun 2015 |
157 |
| 27 |
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)
Ana M. Lluch et al. · Journal of Clinical Oncology
Open access |
5 Dec 2019 |
156 |
| 28 |
A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study
Emilio Alba, José Ignacio Chacón, Ana M. Lluch et al. · Breast Cancer Research and Treatment
Open access |
8 Oct 2012 |
147 |
| 29 |
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses
Clara O. Montagut et al. · JAMA Oncology
Open access |
8 Feb 2018 |
145 |
| 30 |
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL
Miguel Martín et al. · Annals of Oncology
Open access |
29 Dec 2020 |
134 |
| 31 |
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial
Jonathan A. Ledermann et al. · The Lancet Oncology
Open access |
30 Apr 2020 |
132 |
| 32 |
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial
Peter Vink et al. · Cancer
Open access |
Feb 2019 |
123 |
| 33 |
Diagnostic accuracy of sperm DNA degradation index (DDSi) as a potential noninvasive biomarker to identify men with varicocele-associated infertility
Sandro Cassiano Esteves, Jaime Gosálvez, Carmen López‐Fernández et al. · International Urology and Nephrology
Open access |
30 Jul 2015 |
104 |
| 34 |
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects
Miriam Bazán‐Peregrino et al. · Journal for ImmunoTherapy of Cancer
Open access |
Nov 2021 |
102 |
| 35 |
Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis
Bella Pajares, Marina Pollán, Miguel Martín et al. · Breast Cancer Research
Open access |
6 Nov 2013 |
102 |
| 36 |
Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study
Adela Castelló et al. · PLoS ONE
Open access |
15 May 2015 |
102 |
| 37 |
Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: A Rare Cancer Network study
Enis Özyar, Uğur Selek, Siddihartha Laskar et al. · Radiotherapy and Oncology
|
12 Sep 2006 |
97 |
| 38 |
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2
Teresa Mercade Macarulla, Roberto Pazo-Cid, Carmen Guillén‐Ponce et al. · Journal of Clinical Oncology
|
6 Dec 2018 |
95 |
| 39 |
Prioritizing Phase I Treatment Options Through Preclinical Testing on Personalized Tumorgraft
Maria Pia Morelli, Emiliano Calvo, E. Ordonez Ordonez et al. · Journal of Clinical Oncology
Open access |
20 Dec 2011 |
95 |
| 40 |
Response of two species of clams, Ruditapes decussatus and Venerupis pullastra, to starvation: Physiological and biochemical parameters
Marina Albentosa, María José Fernández‐Reiriz, Uxío Labarta et al. · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology
Open access |
14 Nov 2006 |
95 |
| 41 |
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
Rocio García‐Carbonero et al. · Journal for ImmunoTherapy of Cancer
Open access |
Mar 2022 |
92 |
| 42 |
1215O - SC Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer (NSCLC): Results from the phase II PRINCEPS trial
Benjamin Besse, Julien Adam, Nathalie Cozic et al. · Annals of Oncology
Open access |
Sep 2020 |
92 |
| 43 |
Water mass age and aging driving chromophoric dissolved organic matter in the dark global ocean
Teresa S. Catalá, Isabel Reche, Marta Álvarez et al. · Global Biogeochemical Cycles
Open access |
3 Jun 2015 |
92 |
| 44 |
Abemaciclib in combination with pembrolizumab for HR+, HER2− metastatic breast cancer: Phase 1b study
Hope S. Rugo, Peter Kabos, Julia Beck et al. · npj Breast Cancer
Open access |
5 Nov 2022 |
91 |
| 45 |
First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy
Pamela N. Münster, Monica M Mita, Amit Mahipal et al. · Cancer Management and Research
Open access |
Dec 2019 |
89 |
| 46 |
Quality of life impact of treatments for localized prostate cancer: Cohort study with a 5year follow-up
Montse Ferrer, Ferrán Guedea, José Francisco Suárez et al. · Radiotherapy and Oncology
|
9 Jul 2013 |
89 |
| 47 |
DNA breakage detection-FISH (DBD-FISH) in human spermatozoa: technical variants evidence different structural features
José Luís Fernández, Fernando Vázquez-Gundı́n, Arantza Delgado et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis
|
Sep 2000 |
89 |
| 48 |
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial
Emilio Alba, Joan Albanell, Juan de la Haba-Rodríguez et al. · British Journal of Cancer
Open access |
23 Jan 2014 |
83 |
| 49 |
A Randomised Phase 2 Study Combining LY2181308 Sodium (Survivin Antisense Oligonucleotide) with First-line Docetaxel/Prednisone in Patients with Castration-resistant Prostate Cancer
Paweł Wiechno, Bradley G. Somer, Begoña Mellado et al. · European Urology
Open access |
6 Nov 2013 |
83 |
| 50 |
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
Vincenza Conteduca et al. · European Urology
Open access |
26 Oct 2018 |
82 |